fbpx

ALS Signal and PaCTD


Take action

Spread Awareness of ALS Signal

Share resources

I AM ALS debuted the launch of ALS Signal: Clinical Research Dashboard. ALS Signal is a new global resource created by dedicated patients, caregivers and advocates to offer a user-friendly way to discover current ALS-related clinical research, allowing for efficient access to information that is vital to the ongoing efforts to end ALS.

A key component of ALS Signal is the unique Patient-Centric Trial Design (PaCTD) rating system, created by the I AM ALS Clinical Trials Team led by Sandy Morris who is currently living with ALS. This rating evaluates clinical trials for humaneness and efficiency in their trial design. Based on many components laid out in the FDA’s guidelines for ALS trial design released in 2019 this rating assesses for example, how the trial balances those receiving placebo versus the drug, whether those in the trial have access to the treatment after the trial ends, how the design advances the science by including research on the biology of the disease and the treatment’s effects and how accessible the trial is to patients, including the use of telemedicine. This rating does not evaluate drug safety or efficacy in any way. Learn more about the tenets of the PaCTD rating system.

Media Contact: Theresa Garner, theresa@iamals.org

ALS Signal and PaCTD Presented at the 2020 ALS MND Symposium 

ALS Signal and PaCTD Launched


We will find cures for ALS. The only question is when. That answer depends on you.

Stay informed on I AM ALS’ progress and what you can do to help us make hope real.

This field is required

Back to Top

Join us for the 2024 Community Summit!

Join us in Washington DC from May 29th - June 2nd for the 3rd annual ALS Awareness Month flag display and inaugural Community Summit.

Learn more! Continue to the site